Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

NIH 3OTHER 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma 45Lymphoma, Large B-Cell, Diffuse 31Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Burkitt Lymphoma 22Neuroblastoma 20Leukemia 20Lymphoma, Non-Hodgkin 19Sarcoma 12Multiple Myeloma 12Lymphoma, Follicular 12Central Nervous System Neoplasms 12HIV Infections 11Hodgkin Disease 10Lymphoma, Large-Cell, Immunoblastic 9Acquired Immunodeficiency Syndrome 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Mantle-Cell 8Leukemia, Lymphocytic, Chronic, B-Cell 7Neuroectodermal Tumors, Primitive, Peripheral 6Neoplasms, Plasma Cell 6Lymphoma, Large-Cell, Anaplastic 5Lymphoma, B-Cell, Marginal Zone 5Lymphoma, B-Cell 5Leukemia, Biphenotypic, Acute 5Sarcoma, Kaposi 4Sarcoma, Ewing 4Rhabdomyosarcoma 4Neoplasms 4Lymphoma, T-Cell 4Dendritic Cell Sarcoma, Interdigitating 4

Interventions

Vincristine 3Prednisone 3Doxorubicin 3Cyclophosphamide 3Rituximab 2Etoposide 2vandetanib 1motesanib diphosphate 1liposomal doxorubicin 1denileukin diftitox 1Zidovudine 1Valganciclovir 1Tomography, X-Ray Computed 1Sirolimus 1Nivolumab 1Interferons 1Interferon-alpha 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1Echocardiography 1EPOCH protocol 1Caves 1Brentuximab Vedotin 1Bortezomib 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Lymphoproliferative Disorders × Vincristine × Clear all
NCT00092222 2026-06-05

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

NCT00001379 2025-06-19

Treatment and Natural History Study of Lymphomatoid Granulomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
94 enrolled 20 charts
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Lymphoproliferative Disorders, Epstein-Barr Virus Infections

NCT00365274 2014-06-02

SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma

National Cancer Institute (NCI)

Phase 2 Terminated
6 enrolled 3 charts
Lymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡